From medical chat to care in the app
With Counsel, users can get personalized recommendations from medical AI and, when needed, speak with a doctor. Oura and Counsel plan to develop the service so users can turn to it through the app not just with quick questions, but also about test results, chronic conditions and referrals to specialists.
Oura has held a leading position in the smart ring market for years, but competitors RingConn and Ultrahuman are putting the company under increasing pressure. Acquiring Counsel will allow Oura to expand its business and offer users access to medical care.
Oura CEO Tom Hale noted that physiological data helps service members understand their health, while working with Counsel gives them a way to act — from getting prescriptions to reviewing test results and managing chronic conditions.
Funding and deal terms
A year ago, Counsel Health raised $25 million in a Series A round led by Andreessen Horowitz (a16z) and GV. PitchBook estimates that the startup has raised a total of $36 million.
After the acquisition, Counsel will continue working with its current and new corporate partners. The company aims to extend its AI-powered care model beyond Oura’s customer base.
Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer. Seventy of the startup’s employees will join him at the company.
Alagappan said Counsel developed medical AI with an emphasis on trust, safety and accountability, leaving clinical decisions to doctors. Oura’s data — including biometric trends and member engagement — gives doctors additional context for treatment, he said. He also noted that the teams shared views, culture and mission, and that deal discussions had been underway for the past few months.
Oura’s financial performance
Oura’s revenue for the quarter ended September 30 rose 153% year over year to $533 million. For fiscal 2026, the company generated about $1.75 billion in revenue, up 92% from the previous year.
In October 2025, Oura raised $900 million in late-stage financing, bringing its valuation to $11 billion. The Counsel deal was announced several weeks after Oura indefinitely postponed an initial public offering of up to $2.2 billion, citing uncertainty in the IPO market.
Dataist’s take: Oura is linking smart ring data with access to medical professionals, extending the app’s role beyond health tracking. Counsel will continue serving corporate partners, while the deal is not expected to close until the end of 2027.
Daily AI news
Every day we pick what actually matters in AI and explain it plainly — no hype, no filler. Subscribe if you want to follow where the industry is going.
Only what matters — every day
Follow on X